World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
35710
World Ranking
599
National Ranking
36

Medicine

D-Index
105
Citations
36425
World Ranking
6822
National Ranking
391

Heinz Wiendl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Heinz Wiendl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 652 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Heinz Wiendl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Heinz Wiendl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Heinz Wiendl is affiliated with the University of Münster in Germany and specializes in medical research with a focus on neurology. Their work extensively covers multiple sclerosis and related neurological disorders, contributing to the fields of neurology, pathology, immunology, oncology, and molecular biology.

The scientist's research predominantly addresses multiple sclerosis, peripheral neuropathies, neuroinflammation, autoimmune neurological disorders, and chronic lymphocytic leukemia. Key topics investigated include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Myasthenia Gravis and Thymoma
  • Autoimmune Neurological Disorders and Treatments
  • Chronic Lymphocytic Leukemia Research

Heinz Wiendl has published numerous papers in respected journals, with recent works notably appearing in venues such as the New England Journal of Medicine, Brain, Nature Communications, JAMA Neurology, and The Lancet Neurology. Selected recent publications include:

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis (2020), New England Journal of Medicine
  • How patients with multiple sclerosis acquire disability (2022), Brain
  • Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis (2020), Nature Communications
  • Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis (2023), JAMA Neurology
  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023), The Lancet Neurology

The scientist frequently collaborates with a group of researchers including:

  • Sven G. Meuth
  • Catharina C. Groß
  • Luisa Klotz
  • Andreas Schulte-Mecklenbeck
  • Gerd Meyer zu Hörste

Heinz Wiendl's publications are often featured in specialized journals such as:

  • Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Therapeutic Advances in Neurological Disorders

Their scholarly production spans over 700 publications mainly in medicine, with a significant emphasis on neurological sciences and immunology, reflecting a broad and interdisciplinary research portfolio.

Best Publications

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Stephen L. Hauser;Amit Bar-Or;Jeffrey A. Cohen;Giancarlo Comi

  • Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis

    Sabine Wintterle;Bettina Schreiner;Meike Mitsdoerffer;Dagmar Schneider

  • Leitlinien für Diagnostik und Therapie in der Neurologie

    H. C. Diener;C. Weimar;P. Berlit;G. Deuschl

  • Acute disseminated encephalomyelitis: an update.

    Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl

  • Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

    Christian Blank;Juergen Kuball;Simon Voelkl;Heinz Wiendl

  • A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

    Heinz Wiendl;Meike Mitsdoerffer;Valeska Hofmeister;Jörg Wischhusen

  • Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

    David Schafflick;Chenling A. Xu;Maike Hartlehnert;Michael Cole

  • Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

    Christian G. Bien;Jan Bauer;Thomas L. Deckwerth;Heinz Wiendl

  • Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation

    Christoph Kleinschnitz;Nicholas Schwab;Peter Kraft;Ina Hagedorn

  • Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

    Amit Bar-Or;Andrew Pachner;Francoise Menguy-Vacheron;Johanne Kaplan

  • Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature

    Christoph Kleinschnitz;Peter Kraft;Angela Dreykluft;Ina Hagedorn

  • Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

    Bettina Schreiner;Meike Mitsdoerffer;Bernd C. Kieseier;Lieping Chen

  • Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

    Oliver Neuhaus;Cinthia Farina;Alexander Yassouridis;Heinz Wiendl

  • Clinical relevance of brain volume measures in multiple sclerosis.

    Nicola De Stefano;Laura Airas;Nikolaos Grigoriadis;Heinrich P. Mattle

  • The role of regulatory T cells in multiple sclerosis

    Alla L Zozulya;Heinz Wiendl

  • Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

    Nico Melzer;Tobias Ruck;Peter Fuhr;Ralf Gold

  • A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

    Antje Kroner;Matthias Mehling;Bernhard Hemmer;Peter Rieckmann

  • Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

    Heinz Wiendl;Reinhard Hohlfeld

  • Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis

    Ludwig Kappos;Heinz Wiendl;Krzysztof Selmaj;Douglas L. Arnold

  • Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

    H. Wiendl;K. V. Toyka;P. Rieckmann;R. Gold

Frequent Co-Authors

Sven G. Meuth
Sven G. Meuth University of Münster
Luisa Klotz
Luisa Klotz University Hospital Münster
Catharina C. Gross
Catharina C. Gross University of Münster
Bernd C. Kieseier
Bernd C. Kieseier Novartis (Switzerland)
Christoph Kleinschnitz
Christoph Kleinschnitz University of Duisburg-Essen
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Ralf Gold
Ralf Gold Ruhr University Bochum
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Maria Trojano
Maria Trojano University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology often leads students to consider complementary healthcare careers. Many find that nursing provides a practical bridge to apply immunological concepts in clinical settings. For those interested in faster entry into nursing, programs like the easiest accelerated nursing programs offer streamlined paths to earning a Bachelor of Science in Nursing.

For individuals seeking foundational nursing roles without extensive upfront requirements, lpn programs with easiest admission requirements can be an accessible option. Licensed Practical Nurses play a vital role in patient care, including immunological monitoring and support.

Advancing nursing careers often involves becoming a Nurse Practitioner, specializing in areas like immunology or mental health. Those interested can explore flexible study options through easiest online nurse practitioner programs that balance quality education with manageable admissions.

Specialized fields such as Psychiatric Mental Health Nursing benefit from strong clinical experience. Programs known for their practical training, like the top pmhnp programs, enhance job readiness and career prospects in neuroimmunology-related care.

Best Scientists Citing Heinz Wiendl

Trending Scientists